CMF
TNDM icon

Counterpoint Mutual Funds’s Tandem Diabetes Care TNDM Stock Holding History

Counterpoint Mutual Funds’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$243K Sell
12,679
-10,179
-45% -$221K 0.04% 282
2025
Q4 		$502K Sell
22,858
-19,407
-46% -$350K 0.04% 150
2025
Q3 		$513K Buy
+42,265
New +$572K 0.04% 103
2025
Q2 		– Sell
-18,963
Closed -$363K – 439
2025
Q1 		$363K Buy
+18,963
New +$555K 0.05% 213
2023
Q4 		– Sell
-6,393
Closed -$133K – 282
2023
Q3 		$133K Buy
+6,393
New +$176K 0.11% 103

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Counterpoint Mutual Funds's TNDM Position: Q1 2026 in Review

Counterpoint Mutual Funds reduced its Tandem Diabetes Care (TNDM) stake by 45% in Q1 2026, selling an estimated $221K and leaving 12,679 shares worth $243K. The position accounts for 0.04% of the portfolio, ranked #282.

Counterpoint Mutual Funds first reported a position in TNDM in Q3 2023 and has held it in 5 quarters since. The position peaked at $513K in Q3 2025. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Counterpoint Mutual Funds held 12,679 shares of Tandem Diabetes Care worth $243K as of Q1 2026.
  • Counterpoint Mutual Funds sold 10,179 Tandem Diabetes Care shares in Q1 2026, an estimated $221K.
  • Tandem Diabetes Care made up 0.04% of Counterpoint Mutual Funds's portfolio in Q1 2026, its #282 holding.
  • Counterpoint Mutual Funds first reported a position in Tandem Diabetes Care in Q3 2023 and has held it in 5 quarters since.
  • Counterpoint Mutual Funds's Tandem Diabetes Care position peaked at $513K in Q3 2025.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q1 2026, filed 27 Apr 2026.